Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2007Journal of Clinical InvestigationOpen Access

Gene therapy for severe combined immunodeficiency: are we there yet?

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMarina CavazzanaForest Institute
Alain Fischer
Alain FischerUniversité Claude Bernard Lyon 1

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cavazzana et al. (2007) studied this question.

synapsesocial.com/papers/6a763a8bfa1990f79e6149a2https://doi.org/10.1172/jci30953
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV2005 · 206 citations
  2. 2Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft2001 · 288 citations
  3. 3Retrovirus Silencing and Vector Design: Relevance to Normal and Cancer Stem Cells?2005 · 63 citations
  4. 4Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell–immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype2007 · 232 citations
  5. 5Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy2007 · 257 citations